Morgan Stanley’s Ovid Therapeutics OVID Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.49K | Sell |
10,565
-72,162
| -87% | -$23.8K | ﹤0.01% | 7123 |
|
|
2025
Q1 | $25.8K | Sell |
82,727
-106,760
| -56% | -$33.3K | ﹤0.01% | 6474 |
|
|
2024
Q4 | $177K | Buy |
189,487
+23,657
| +14% | +$22.1K | ﹤0.01% | 5837 |
|
|
2024
Q3 | $196K | Buy |
165,830
+96,880
| +141% | +$114K | ﹤0.01% | 5761 |
|
|
2024
Q2 | $53K | Sell |
68,950
-31,003
| -31% | -$23.8K | ﹤0.01% | 6149 |
|
|
2024
Q1 | $305K | Sell |
99,953
-167,927
| -63% | -$512K | ﹤0.01% | 5550 |
|
|
2023
Q4 | $863K | Buy |
267,880
+224,763
| +521% | +$724K | ﹤0.01% | 5368 |
|
|
2023
Q3 | $166K | Sell |
43,117
-10,527
| -20% | -$40.4K | ﹤0.01% | 5668 |
|
|
2023
Q2 | $176K | Buy |
53,644
+20,782
| +63% | +$68.2K | ﹤0.01% | 5701 |
|
|
2023
Q1 | $84.8K | Buy |
32,862
+29,321
| +828% | +$75.6K | ﹤0.01% | 6077 |
|
|
2022
Q4 | $6.59K | Sell |
3,541
-12,518
| -78% | -$23.3K | ﹤0.01% | 7078 |
|
|
2022
Q3 | $30K | Sell |
16,059
-4,812
| -23% | -$8.99K | ﹤0.01% | 6622 |
|
|
2022
Q2 | $45K | Buy |
20,871
+1,801
| +9% | +$3.88K | ﹤0.01% | 6662 |
|
|
2022
Q1 | $60K | Sell |
19,070
-2,395
| -11% | -$7.54K | ﹤0.01% | 6620 |
|
|
2021
Q4 | $69K | Sell |
21,465
-23,969
| -53% | -$77K | ﹤0.01% | 6646 |
|
|
2021
Q3 | $153K | Sell |
45,434
-144,766
| -76% | -$488K | ﹤0.01% | 6134 |
|
|
2021
Q2 | $743K | Buy |
190,200
+112,266
| +144% | +$439K | ﹤0.01% | 5256 |
|
|
2021
Q1 | $314K | Sell |
77,934
-72,179
| -48% | -$291K | ﹤0.01% | 5395 |
|
|
2020
Q4 | $347K | Buy |
150,113
+20,587
| +16% | +$47.6K | ﹤0.01% | 5285 |
|
|
2020
Q3 | $744K | Sell |
129,526
-21,361
| -14% | -$123K | ﹤0.01% | 4417 |
|
|
2020
Q2 | $1.11M | Buy |
150,887
+28,826
| +24% | +$213K | ﹤0.01% | 4086 |
|
|
2020
Q1 | $364K | Sell |
122,061
-220,115
| -64% | -$656K | ﹤0.01% | 4556 |
|
|
2019
Q4 | $1.42M | Buy |
342,176
+282,933
| +478% | +$1.17M | ﹤0.01% | 4291 |
|
|
2019
Q3 | $192K | Buy |
59,243
+7,169
| +14% | +$23.2K | ﹤0.01% | 5151 |
|
|
2019
Q2 | $96K | Sell |
52,074
-73,832
| -59% | -$136K | ﹤0.01% | 5344 |
|
|
2019
Q1 | $224K | Buy |
125,906
+87,238
| +226% | +$155K | ﹤0.01% | 4996 |
|
|
2018
Q4 | $93K | Sell |
38,668
-13,099
| -25% | -$31.5K | ﹤0.01% | 5581 |
|
|
2018
Q3 | $293K | Buy |
51,767
+23,105
| +81% | +$131K | ﹤0.01% | 5278 |
|
|
2018
Q2 | $223K | Buy |
28,662
+991
| +4% | +$7.71K | ﹤0.01% | 5490 |
|
|
2018
Q1 | $196K | Buy |
27,671
+1,014
| +4% | +$7.18K | ﹤0.01% | 5477 |
|
|
2017
Q4 | $264K | Buy |
26,657
+19,752
| +286% | +$196K | ﹤0.01% | 5310 |
|
|
2017
Q3 | $59K | Buy |
6,905
+1,848
| +37% | +$15.8K | ﹤0.01% | 5736 |
|
|
2017
Q2 | $53K | Buy |
+5,057
| New | +$53K | ﹤0.01% | 5839 |
|